Company Mithra Pharmaceuticals S.A.

Equities

MITRA

BE0974283153

Pharmaceuticals

Market Closed - Euronext Bruxelles 11:35:26 2024-04-26 am EDT 5-day change 1st Jan Change
0.216 EUR -1.82% Intraday chart for Mithra Pharmaceuticals S.A. -.--% -82.78%

Business Summary

Mithra Pharmaceuticals S.A. is a Belgian biotech company dedicated to transforming Women's Health by offering new choices through innovation, with a particular focus on contraception and menopause. Mithra's goal is to develop products offering better efficacy, safety and convenience, meeting women's needs throughout their life span.

Mithra Pharmaceuticals S.A. explores the potential of the unique native estrogen estetrol in a wide range of applications in women health and beyond. After having successfully launched the first estetrol-based product in 2021, the contraceptive pill Estelle®, the Company is now focusing on its second product Donesta®, the next-generation hormone therapy.

Mithra Pharmaceuticals S.A. also develops and manufactures complex therapeutics in the areas of contraception, menopause and hormone-dependent cancers. It offers partners a complete spectrum of research, development and specialist manufacturing at its technological platform Mithra CDMO.

Number of employees: 270

Sales per Business

EUR in Million2021Weight2022Weight Delta
Therapeutic Products
100.0 %
23 100.0 % 67 100.0 % +195.56%

Sales per region

EUR in Million2021Weight2022Weight Delta
Europe
76.6 %
9 41.0 % 51 76.6 % +452.76%
International
21.1 %
12 54.6 % 14 21.1 % +14.23%
Belgium
2.3 %
1 4.5 % 2 2.3 % +51.98%

Managers

Managers TitleAgeSince
Chief Executive Officer - 17-02-22
Chief Tech/Sci/R&D Officer - 21-04-30
Chief Tech/Sci/R&D Officer 63 19-03-31
Corporate Secretary - -
Human Resources Officer - 20-12-31
General Counsel - -
Corporate Officer/Principal - 08-12-31
Corporate Officer/Principal - 12-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 53 23-05-28
Chairman 65 23-05-28
Director/Board Member 51 21-05-19
Founder 75 99-07-07
Director/Board Member - 23-05-28

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 69,108,397 56,443,924 ( 81.67 %) 0 81.67 %

Shareholders

NameEquities%Valuation
10,986,383 15.90 % 3 M €
Noshaq SA
7.908 %
5,465,164 7.908 % 1 M €
4,471,408 6.470 % 1 M €
1,641,407 2.375 % 379 099 €
BNP Paribas Asset Management Belgium SA
0.5206 %
359,750 0.5206 % 83 088 €
BLI - Banque de Luxembourg Investments SA
0.1182 %
81,666 0.1182 % 18 862 €
FundQuest Advisor
0.0988 %
68,262 0.0988 % 15 766 €
EME Partners AB
0.004341 %
3,000 0.004341 % 693 €
Candriam France SAS
0.000470 %
325 0.000470 % 75 €

Holdings

NameEquities%Valuation
4,221,815 4.96% 19,107,808 $

Company contact information

Mithra Pharmaceuticals SA

rue Saint-Georges 5

4000, Liege

+32 4 349 28 22

http://www.mithra.com
address Mithra Pharmaceuticals S.A.(MITRA)

Group companies

NameCategory and Sector
Pharmaceuticals: Major

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
0.216 EUR
Average target price
0.1 EUR
Spread / Average Target
-53.70%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. MITRA Stock
  4. Company Mithra Pharmaceuticals S.A.